rs12261752

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBA1

The NM_138413.4(HOGA1):​c.912C>A​(p.Ala304Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.304 in 1,613,966 control chromosomes in the GnomAD database, including 76,576 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.30 ( 7081 hom., cov: 33)
Exomes 𝑓: 0.30 ( 69495 hom. )

Consequence

HOGA1
NM_138413.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts U:1B:11

Conservation

PhyloP100: -0.248

Publications

14 publications found
Variant links:
Genes affected
HOGA1 (HGNC:25155): (4-hydroxy-2-oxoglutarate aldolase 1) The authors of PMID:20797690 cloned this gene while searching for genes in a region of chromosome 10 linked to primary hyperoxalurea type III. They noted that even though the encoded protein has been described as a mitochondrial dihydrodipicolinate synthase-like enzyme, it shares little homology with E. coli dihydrodipicolinate synthase (Dhdps), particularly in the putative substrate-binding region. Moreover, neither lysine biosynthesis nor sialic acid metabolism, for which Dhdps is responsible, occurs in vertebrate mitochondria. They propose that this gene encodes mitochondrial 4-hydroxyl-2-oxoglutarate aldolase (EC 4.1.3.16), which catalyzes the final step in the metabolic pathway of hydroxyproline, releasing glyoxylate and pyruvate. This gene is predominantly expressed in the liver and kidney, and mutations in this gene are found in patients with primary hyperoxalurea type III. Alternatively spliced transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Nov 2010]
HOGA1 Gene-Disease associations (from GenCC):
  • primary hyperoxaluria type 3
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Myriad Women’s Health, Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.24).
BP6
Variant 10-97611587-C-A is Benign according to our data. Variant chr10-97611587-C-A is described in ClinVar as Benign. ClinVar VariationId is 204264.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.381 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_138413.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HOGA1
NM_138413.4
MANE Select
c.912C>Ap.Ala304Ala
synonymous
Exon 7 of 7NP_612422.2
HOGA1
NM_001134670.2
c.423C>Ap.Ala141Ala
synonymous
Exon 3 of 3NP_001128142.1Q86XE5-3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HOGA1
ENST00000370646.9
TSL:1 MANE Select
c.912C>Ap.Ala304Ala
synonymous
Exon 7 of 7ENSP00000359680.4Q86XE5-1
HOGA1
ENST00000370647.8
TSL:1
c.423C>Ap.Ala141Ala
synonymous
Exon 3 of 3ENSP00000359681.4Q86XE5-3
ENSG00000249967
ENST00000370649.3
TSL:2
c.345+9597C>A
intron
N/AENSP00000359683.3E9PAM4

Frequencies

GnomAD3 genomes
AF:
0.301
AC:
45792
AN:
152082
Hom.:
7064
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.307
Gnomad AMI
AF:
0.388
Gnomad AMR
AF:
0.257
Gnomad ASJ
AF:
0.356
Gnomad EAS
AF:
0.376
Gnomad SAS
AF:
0.395
Gnomad FIN
AF:
0.241
Gnomad MID
AF:
0.332
Gnomad NFE
AF:
0.300
Gnomad OTH
AF:
0.302
GnomAD2 exomes
AF:
0.301
AC:
75578
AN:
251064
AF XY:
0.309
show subpopulations
Gnomad AFR exome
AF:
0.309
Gnomad AMR exome
AF:
0.210
Gnomad ASJ exome
AF:
0.349
Gnomad EAS exome
AF:
0.370
Gnomad FIN exome
AF:
0.254
Gnomad NFE exome
AF:
0.295
Gnomad OTH exome
AF:
0.302
GnomAD4 exome
AF:
0.305
AC:
445215
AN:
1461766
Hom.:
69495
Cov.:
37
AF XY:
0.308
AC XY:
224023
AN XY:
727180
show subpopulations
African (AFR)
AF:
0.315
AC:
10558
AN:
33478
American (AMR)
AF:
0.217
AC:
9694
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.350
AC:
9139
AN:
26136
East Asian (EAS)
AF:
0.418
AC:
16589
AN:
39698
South Asian (SAS)
AF:
0.397
AC:
34241
AN:
86254
European-Finnish (FIN)
AF:
0.255
AC:
13622
AN:
53366
Middle Eastern (MID)
AF:
0.320
AC:
1848
AN:
5768
European-Non Finnish (NFE)
AF:
0.297
AC:
330210
AN:
1111954
Other (OTH)
AF:
0.320
AC:
19314
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
18218
36436
54653
72871
91089
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
11042
22084
33126
44168
55210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.301
AC:
45842
AN:
152200
Hom.:
7081
Cov.:
33
AF XY:
0.299
AC XY:
22234
AN XY:
74404
show subpopulations
African (AFR)
AF:
0.307
AC:
12755
AN:
41530
American (AMR)
AF:
0.257
AC:
3937
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.356
AC:
1235
AN:
3472
East Asian (EAS)
AF:
0.377
AC:
1945
AN:
5166
South Asian (SAS)
AF:
0.396
AC:
1909
AN:
4826
European-Finnish (FIN)
AF:
0.241
AC:
2556
AN:
10606
Middle Eastern (MID)
AF:
0.337
AC:
99
AN:
294
European-Non Finnish (NFE)
AF:
0.300
AC:
20415
AN:
67990
Other (OTH)
AF:
0.302
AC:
638
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1695
3390
5084
6779
8474
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
478
956
1434
1912
2390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.301
Hom.:
5641
Bravo
AF:
0.302
Asia WGS
AF:
0.403
AC:
1400
AN:
3478
EpiCase
AF:
0.300
EpiControl
AF:
0.291

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
4
Primary hyperoxaluria type 3 (5)
-
-
4
not specified (4)
-
-
3
not provided (3)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.24
CADD
Benign
7.8
DANN
Benign
0.77
PhyloP100
-0.25
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12261752; hg19: chr10-99371344; COSMIC: COSV56729407; COSMIC: COSV56729407; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.